Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
- Status
- COMPLETED
- Phase
- PHASE3
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- N/A
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2